Anti-CD40L antibody (Bristol-Myers Squibb)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAnti-CD40L antibody (Bristol-Myers Squibb)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionCD40 ligand inhibitors
TargetsCD40 ligand
Therapy Area/IndicationsImmunologic Deficiency Syndromes
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesBristol-Myers Squibb Company
Inactive CompaniesN/A
Active IndicationsImmunologic Deficiency Syndromes
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A